The Association Between Type 2 Diabetes and Cardiovascular Disease: The “For Your SweetHeart™” Survey

por Perreault, Leigh, Boardman, Marilyn K., Pak, Jonathan
Publicado 2019

Safety of exenatide once weekly for 52 weeks in Japanese patients with type 2 diabetes mellitus

por Onishi, Yukiko, Koshiyama, Hiroyuki, Imaoka, Takeshi, Haber, Harry, Scism‐Bacon, Jamie, Boardman, Marilyn K
Publicado 2012

Improved glycemic control and reduced bodyweight with exenatide: A double‐blind, randomized, phase 3 study in Japanese patients with suboptimally controlled type 2 diabetes over 24...

por Kadowaki, Takashi, Namba, Mitsuyoshi, Imaoka, Takeshi, Yamamura, Ayuko, Goto, Wakana, Boardman, Marilyn K., Sowa, Hideaki
Publicado 2010

Efficacy and safety of exenatide once‐weekly vs exenatide twice‐daily in Asian patients with type 2 diabetes mellitus

por Ji, Linong, Onishi, Yukiko, Ahn, Chul Woo, Agarwal, Pankaj, Chou, Chien‐Wen, Haber, Harry, Guerrettaz, Kelly, Boardman, Marilyn K
Publicado 2013

Efficacy and Safety of Exenatide Once Weekly Versus Metformin, Pioglitazone, and Sitagliptin Used as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4): A 26-week...

por Russell-Jones, David, Cuddihy, Robert M., Hanefeld, Markolf, Kumar, Ajay, González, Jose G., Chan, Melanie, Wolka, Anne M., Boardman, Marilyn K.
Publicado 2012

Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes

por Simeone, Jason C, Bae, Jay P, Hoogwerf, Byron J, Li, Qian, Haupt, Axel, Ali, Ayad K, Boardman, Marilyn K, Nordstrom, Beth L
Publicado 2017